ARTICLE SUMMARY:
In 2021, medtech will grapple with ways to capture the pandemic rebound opportunity through value-adding new technologies and responsiveness to the complexities and diversity of the shifting US healthcare system. In late January, a panel of experts spoke with MedTech Strategist about these challenges.
On January 22, MedTech Strategist convened a panel to discuss the outlook for the medical device industry as it emerges from pandemic. Panelists included Jacob Paul, SVP Medtronic Cranial and Spinal Technologies, Jim Archetto, VP Guamard Scientific, Ryan Zimmerman, Managing Director and Medtech Analyst, BTIG, and Brian Chapman, Principal at ZS Associates.
Subscribers can watch the panel video below.
